IP Library Granted Patent US 8,287,461
Granted Patent B2
US 8,287,461 · App. 11/939,082 · Granted Oct 16, 2012

Vein identification technique

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,287,461
App. No.
11/939,082
Granted
Oct 16, 2012
Kind
B2
Abstract

A technique for identifying a vein in a patient is disclosed. The technique involves the application of a thermochromic ink to a venous area on the skin of a patient (e.g., human or animal). The thermochromic ink comprises thermosensitive color-changing microcapsules that contain a proton-accepting chromogen and a desensitizer. The desensitizer possesses a melting point above which the chromogen is capable of becoming protonated, thereby resulting in a color change. Thereafter, the venous area is observed for the color change.

Claims (24)

1. A method for identifying a vein in a patient, the method comprising:

placing a thermochromic ink in direct contact with a venous area on the skin of a patient, wherein the thermochromic ink comprises thermosensitive color-changing microcapsules that contain a proton-accepting chromogen and a desensitizer, wherein the desensitizer possesses a melting point above which the chromogen is capable of becoming protonated, thereby resulting in a color change; and

thereafter, observing the venous area for the color change.

2. The method of claim 1 , wherein the proton-accepting chromogen is a leuco dye.

3. The method of claim 2 , wherein the leuco dye includes a phthalide, phthalene, acyl-leucomethylene, fluorane, spiropyrane, cumarin, or a combination thereof.

4. The method of claim 1 , wherein proton-accepting chromogens constitute from about 0.1 wt.% to about 20 wt.% of the microcapsules.

5. The method of claim 1 , wherein the desensitizer has a boiling point of about 150° C. or higher.

6. The method of claim 1 , wherein the desensitizer has a melting point of about from about 26° C. to about 34° C.

7. The method of claim 1 , wherein the desensitizer includes a saturated or unsaturated alcohol, an ester of a saturated or unsaturated alcohol, an amide, or a combination thereof.

8. The method of claim 1 , wherein desensitizers constitute from about 10 wt. % to about 70 wt. % of the microcapsules.

9. The method of claim 1 , wherein the microcapsules further comprises a proton-donating agent.

10. The method of claim 9 , wherein proton-donating agents constitute from about 0.5 wt. % to about 30 wt. % of the microcapsules.

11. The method of claim 1 , wherein the microcapsules are formed from a polymer resin.

12. The method of claim 11 , wherein polymer resins constitute from about 20 wt. % to about 80 wt. % of the microcapsules.

13. The method of claim 1 , wherein the microcapsules having a mean particle size of from 10 nanometers to about 10 micrometers.

14. The method of claim 1 , wherein the chromogen undergoes a color change at a temperature of from about 26° C. to about 34° C.

15. The method of claim 1 , wherein the chromogen undergoes a color change at a temperature of from about 28° C. to about 33° C.

16. The method of claim 1 , wherein the thermochromic ink further comprises a cooling agent.

17. The method of claim 16 , wherein the cooling agent has an enthalpy of vaporization of about 40 kilojoules per mole or less.

18. The method of claim 16 , wherein the cooling agent is an alcohol.

19. The method of claim 16 , wherein cooling agents constitute from about 50 wt. % to about 99.9 wt. % of the ink and the microcapsules constitute from about 0.1 wt.% to about 50 wt. % of the ink.

20. The method of claim 16 , wherein cooling agents constitute from about 30 wt. % to about 99 wt. % of the ink and the microcapsules constitute from about 1 wt. % to about 70 wt. % of the ink.

21. The method of claim 1 , wherein the thermochromic ink is disposed on a substrate.

22. The method of claim 21 , wherein the substrate contains a nonwoven web.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034753/0360 →